Skip to main content

Launch of clinical care standard for psychotropic medicines

You are invited to the online launch of the first national Psychotropic Medicines in Cognitive Disability or Impairment Clinical Care Standard, hosted by the Australian Commission on Safety and Quality in Health Care.

Psychotropic medications are frequently prescribed to people who live with cognitive disability or impairment – and are often used to manage behaviours of concern, despite the lack of evidence that they are effective for this purpose.

The standard has been developed by clinicians and researchers working in both the aged care and disability sectors to improve the quality of health care for people with cognitive disability or impairment, whenever these medicines are being considered or used.

Join our webcast to hear experts discuss informed consent, adequate assessment, best use of non-medication strategies and how to optimise safety when psychotropic medicines are considered necessary.

When: Thursday 9 May 12:00 – 1:00 pm AEST

Register now

Expert panellists

Award-winning ABC journalist Tegan Taylor will host an expert panel including: 

Conjoint Associate Professor Carolyn Hullick Chief Medical Officer, Australian Commission on Safety and Quality in Health Care
Associate Professor Juanita Breen Dementia Research, University of Tasmania
Professor Eddy Strivens AM PSM Geriatrician and Clinical Director, Cairns and Hinterland Hospital and Health Service
Professor Julian Trollor Chair, Intellectual Disability Mental Health, University of New South Wales

This event is relevant to all healthcare workers involved in providing care to people with cognitive disability or impairment.

The standard was developed following a Joint Statement between the Australian Commission on Safety and Quality in Health Care, the Aged Care Quality and Safety Commission and the NDIS Quality and Safeguards Commission, outlining their commitment to working together to reduce the inappropriate use of psychotropic medicines.

Please share this invitation with anyone in your network who may be interested.

Back to top